Literature DB >> 7902177

Adenylate cyclase-mediated vascular responses of rabbit aorta, mesenteric artery and skin microcirculation.

A J Wilson1, J B Warren.   

Abstract

1. The importance of adenylate cyclase-mediated vascular relaxation in the macro and microcirculation was assessed in rabbit aortic and coeliac artery bioassay rings in vitro and skin microvessels in vivo. 2. The neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP38), the beta-agonist, isoprenaline, and the prostaglandins, PGE1 and PGE2, were compared with the activity of nitroprusside, which acts by stimulating guanylate cyclase. 3. In aortic tissue the relative relaxant potencies were (-log M EC50, 100% = response to nitroprusside 10(-6) M): nitroprusside 7.0, PACAP38 6.8, isoprenaline 6.3; PGE1 and PGE2 were weak constrictors. In coeliac artery rings relative potencies were (-log M EC50, 100% = response to nitroprusside 10(-5) M): PACAP38 6.6, PGE1 6.6, nitroprusside 6.5, PGE2 4.9, and isoprenaline 4.3. 4. Comparative potencies when injected into anaesthetized rabbit skin in vivo were (-log mol/site required to increase blood red cell flux by 75%): PACAP38 13.0, PGE2 10.7, isoprenaline 9.7, PGE1 9.1, nitroprusside < 7. 5. Nitroprusside, the most effective relaxant tested in the aorta, was 10(7) fold less potent than PACAP in its effect on skin blood flow. PGE1 and PGE2 were constrictors of the aorta, of intermediate effect in the coeliac artery, but potent vasodilators of the microcirculation. 6. In this model, the importance of adenylate cyclase-mediated vascular relaxation increases with decreasing vessel size.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902177      PMCID: PMC2175949          DOI: 10.1111/j.1476-5381.1993.tb13858.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Mechanism of beta-adrenergic relaxation of smooth muscle.

Authors:  C R Scheid; T W Honeyman; F S Fay
Journal:  Nature       Date:  1979-01-04       Impact factor: 49.962

2.  Role of cyclic AMP and Ca ++ in mechanical and metabolic events in isometrically contracting vascular smooth muscle.

Authors:  R Andersson
Journal:  Acta Physiol Scand       Date:  1973-01

3.  Endogenous nitric oxide as a modulator of rabbit skeletal muscle microcirculation in vivo.

Authors:  M G Persson; L E Gustafsson; N P Wiklund; P Hedqvist; S Moncada
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

4.  Simultaneous measurements of macromolecular leakage and arteriolar blood flow as altered by PGE1 and beta 2-receptor stimulant in the hamster cheek pouch.

Authors:  W L Joyner; E Svensjö; K E Arfors
Journal:  Microvasc Res       Date:  1979-11       Impact factor: 3.514

5.  Microcirculatory responses to prostacyclin and PGE2 in the rat cremaster muscle.

Authors:  E J Messina; G Kaley
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1980

6.  Microcirculatory effects of arachidonic acid and a prostaglandin endoperoxide (PGH2).

Authors:  E J Messina; J Rodenburg; B L Slomiany; A M Roberts; T H Hintze; G Kaley
Journal:  Microvasc Res       Date:  1980-05       Impact factor: 3.514

7.  Role of prostaglandin-mediated vasodilatation in inflammation.

Authors:  T J Williams; M J Peck
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

8.  Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation.

Authors:  S Bunting; R Gryglewski; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1976-12

9.  Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo.

Authors:  J B Warren; R K Loi; M L Coughlan
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

10.  Inhibition of bradykinin vasodilation and potentiation of norepinephrine and angiotensin vasoconstriction by inhibitors of prostaglandin synthesis in skeletal muscle of the rat.

Authors:  E J Messina; R Weiner; G Kaley
Journal:  Circ Res       Date:  1975-10       Impact factor: 17.367

View more
  7 in total

1.  Arteriolar dilation to endotoxin is increased in copper-deficient rats.

Authors:  D A Schuschke; J T Saari; F N Miller
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

2.  Alpha 2-adrenoceptor mediated inhibition of forskolin-stimulated cyclic AMP accumulation in isolated porcine palmar lateral veins.

Authors:  I K Wright; D A Kendall; V G Wilson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

3.  Pituitary adenylate cyclase-activating polypeptide (PACAP) induces relaxations of peripheral and cerebral arteries, which are differentially impaired by aging.

Authors:  Zoltan Vamos; Ivan Ivic; Peter Cseplo; Gabor Toth; Andrea Tamas; Dora Reglodi; Akos Koller
Journal:  J Mol Neurosci       Date:  2014-06-19       Impact factor: 3.444

4.  cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.

Authors:  M A Moro; R J Russel; S Cellek; I Lizasoain; Y Su; V M Darley-Usmar; M W Radomski; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

5.  Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents.

Authors:  Lionel Fizanne; Dominique Sigaudo-Roussel; Jean Louis Saumet; Bérengère Fromy
Journal:  J Physiol       Date:  2003-10-24       Impact factor: 5.182

6.  Pituitary adenylate cyclase activating polypeptide (PACAP) dilates cerebellar arteries through activation of large-conductance Ca(2+)-activated (BK) and ATP-sensitive (K ATP) K (+) channels.

Authors:  Masayo Koide; Arsalan U Syed; Karen M Braas; Victor May; George C Wellman
Journal:  J Mol Neurosci       Date:  2014-04-18       Impact factor: 3.444

7.  Potentiation by forskolin of both SNP- and ANP-stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein.

Authors:  I K Wright; S Amirchetty-Rao; D A Kendall
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.